FDA warns on use of certain migraine drugs during pregnancy
May 06, 2013 at 14:07 PM EDT
May 6 (Reuters) - The U.S. Food and Drug Administration warned on the use of migraine drug valproate sodium in pregnant women as it could result in lower IQ scores in the baby.